Symrise AG (SY1)

Basic

  • Market Cap

    €14.82B

  • EV

    €17.3B

  • Shares Out

    139.77M

  • Revenue

    €4,771.82M

  • Employees

    12,265

Margins

  • Gross

    35.84%

  • EBITDA

    18.15%

  • Operating

    12.04%

  • Pre-Tax

    7.78%

  • Net

    5%

  • FCF

    7.65%

Returns (5Yr Avg)

  • ROA

    5.19%

  • ROE

    12.46%

  • ROCE

    10.03%

  • ROIC

    7.06%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €107.55

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    €34.09

  • Earnings (Dil)

    €1.7

  • FCF

    €2.6

  • Book Value

    €25.12

Growth (CAGR)

  • Rev 3Yr

    10.5%

  • Rev 5Yr

    9.32%

  • Rev 10Yr

    10.25%

  • Dil EPS 3Yr

    -9.12%

  • Dil EPS 5Yr

    -3.66%

  • Dil EPS 10Yr

    2.05%

  • Rev Fwd 2Yr

    4.23%

  • EBITDA Fwd 2Yr

    6.17%

  • EPS Fwd 2Yr

    8.6%

  • EPS LT Growth Est

    13.61%

Dividends

  • Yield

  • Payout

    61.57%

  • DPS

    €1.05

  • DPS Growth 3Yr

    3.39%

  • DPS Growth 5Yr

    3.6%

  • DPS Growth 10Yr

    4.91%

  • DPS Growth Fwd 2Yr

    7.93%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM

Total Revenues

3,154.0

3,407.9

3,520.5

3,825.7

4,618.5

4,771.8

Total Revenues % Chg.

5.3%

8.0%

3.3%

8.7%

20.7%

14.2%

Cost of Goods Sold, Total

1,912.6

2,047.3

2,130.0

2,346.9

2,916.4

3,061.7

Gross Profit

1,241.5

1,360.6

1,390.5

1,478.8

1,702.1

1,710.1

Selling General & Admin Expenses, Total

664.2

716.7

736.7

784.7

935.0

964.1

R&D Expenses

200.4

213.4

212.3

220.7

254.5

262.1

Other Operating Expenses

-47.6

-42.2

-8.6

-23.1

-105.7

-90.6

Other Operating Expenses, Total

817.0

887.9

940.5

982.4

1,083.8

1,135.6

Operating Income

424.5

472.7

450.0

496.4

618.2

574.5

Interest Expense, Total

-32.6

-51.4

-57.8

-38.9

-58.9

-80.6

Interest And Investment Income

4.6

4.9

3.0

3.6

7.8

11.2

Net Interest Expenses

-27.9

-46.5

-54.8

-35.3

-51.1

-69.4

Income (Loss) On Equity Invest.

-1.2

3.5

4.7

-113.3

-111.2

Currency Exchange Gains (Loss)

-9.2

-0.5

-9.6

-8.2

0.2

0.2

Other Non Operating Income (Expenses)

1.7

1.3

0.5

12.9

-16.5

-16.5

EBT, Excl. Unusual Items

389.0

425.7

389.6

470.6

437.5

377.5

Merger & Related Restructuring Charges

-16.3

-3.5

-3.5

Impairment of Goodwill

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

0.2

13.2

36.2

Asset Writedown

Insurance Settlements

12.3

2.5

2.5

Other Unusual Items

20.8

-2.9

-5.4

-5.4

EBT, Incl. Unusual Items

389.0

409.5

423.6

516.2

431.1

371.1

Income Tax Expense

109.4

111.6

108.6

131.2

140.4

124.5

Earnings From Continuing Operations

279.7

297.9

315.0

385.0

290.7

246.6

Minority Interest

-4.4

-6.8

-8.1

-10.1

-10.7

-7.9

Net Income

275.3

291.1

306.9

374.9

280.0

238.7

Net Income to Common Incl Extra Items

275.3

291.1

306.9

374.9

280.0

238.7

Net Income to Common Excl. Extra Items

275.3

291.1

306.9

374.9

280.0

238.7

Total Shares Outstanding

129.8

135.4

135.4

139.8

139.8

140.0

Weighted Avg. Shares Outstanding

129.8

134.8

135.4

136.6

139.8

140.0

Weighted Avg. Shares Outstanding Dil

134.2

139.2

139.8

138.9

140.0

140.2

EPS

2.1

2.2

2.3

2.7

2.0

1.7

EPS Diluted

2.1

2.1

2.2

2.7

2.0

1.7

EBITDA

620.0

701.5

703.5

748.9

907.6

866.1